NUVB: Nuvation Bio Inc.
Performance
NUVB -8.03%
Watchlist
Select an item
Summary
NUVB at a glance
NUVB returned -8.03% over the past year and -13.88% a year over five years. Its worst drop in that year was -57.55%, smaller than 14% of stocks on Redstone, and its Sharpe ratio of 0.24 beats 38% of stocks on Redstone. It pays no dividends.
Current Drawdown
-54.40%
Rolling Volatility
60.41%
Actions
Metrics
Risk Indicators
Alpha2.99%
Beta1.71x
Sharpe0.24
Sortino0.39
Omega1.05
Calmar-0.14
Martin0.49
Profile
About NUVB
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.5B
- Listed
- Feb 2021
- Employees
- 305
- Headquarters
- New York, NY
- Website
- nuvationbio.com
Comparisons